From bioengineers to interventional cardiologists, molecular biologists to cardiothoracic surgeons, experts with diverse backgrounds are focusing on the problem of heart valve disease in children.
Whole exome sequencing has the ability to identify disease-causing mutations, contributing to the development of personalized medicine and bridging a crucial gap between scientific knowledge and clinical application.
Optimal timing of procedures and reduction of adverse events are avenues for future study.
Loss of TgfB1 from the endothelium leads to a reduction in Sox9 expression and valve calcification.
Recent studies show the practice can offer circulatory advantages for infants born extremely preterm or with critical congenital heart disease.
Cardiac MRI for Hypoplastic Left Heart Syndrome
The jury is still out on whether universal testing of children is a good thing.
